{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:46:27Z","timestamp":1791405987485,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.neurobiolaging.2004.09.003","type":"journal-article","created":{"date-parts":[[2004,12,9]],"date-time":"2004-12-09T17:58:50Z","timestamp":1102615130000},"page":"355-361","source":"Crossref","is-referenced-by-count":124,"title":["Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Judes","family":"Poirier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1523\/JNEUROSCI.17-02-00516.1997","article-title":"Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele","volume":"17","author":"Arendt","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(99)01894-6","article-title":"Apolipoprotein E and \u03b2-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependant","volume":"843","author":"Beffert","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0173(98)00008-3","article-title":"The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease","volume":"27","author":"Beffert","year":"1998","journal-title":"Br Res Rev"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib4","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1172\/JCI113943","article-title":"A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve","volume":"83","author":"Boyles","year":"1989","journal-title":"J. Clin Invest"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib5","first-page":"2168","article-title":"Regulation of cholesterol synthesis in normal and malignant tissue","volume":"32","author":"Brown","year":"1973","journal-title":"Fed Proc"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1212\/WNL.59.8.1257","article-title":"Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide","volume":"59","author":"Fassbender","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.52.2.244","article-title":"Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury","volume":"52","author":"Friedman","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/35036221","article-title":"Apolipoprotein E receptors: linking brain development and Alzheimer's disease","volume":"1","author":"Herz","year":"2000","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib9","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","article-title":"Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease","volume":"103","author":"Holtzman","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(03)00895-4","article-title":"Pravastatin at 10mg\/day does not decrease plasma levels of either amyloid-beta (Abeta) 40 or Abeta 42 in humans","volume":"350","author":"Ishii","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib11","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1212\/WNL.47.1.166","article-title":"Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality","volume":"47","author":"Knopman","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H","article-title":"Association of human, rat, and rabbit apolipoprotein E with beta- amyloid","volume":"49","author":"LaDu","year":"1997","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/hmg\/9.1.57","article-title":"Independent association of an ApoE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations\u2014the ECTIM study","volume":"9","author":"Lambert","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ana.410380420","article-title":"Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease","volume":"38","author":"Levy-Lahad","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib16","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/WNL.55.10.1536","article-title":"Apolipoprotein E and functional recovery from brain injury following post-acute rehabilitation","volume":"55","author":"Lichtman","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease","volume":"541","author":"Namba","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0304-3940(92)90531-B","article-title":"Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease","volume":"134","author":"Namba","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib19","first-page":"525","article-title":"Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease","volume":"17","author":"Poirier","year":"1994","journal-title":"TINS"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1471-4914(03)00007-8","article-title":"Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease","volume":"9","author":"Poirier","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0306-4522(93)90456-P","article-title":"Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats","volume":"55","author":"Poirier","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer's disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib23","first-page":"36","article-title":"Apolipoprotein E: a novel therapeutic target for the treatment of Alzheimer's disease","author":"Poirier","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.59.2.223","article-title":"Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people","volume":"59","author":"Rockwood","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib25","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.112","article-title":"Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins","volume":"49","author":"Tokuda","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib27","first-page":"339","article-title":"Genetics of the apolipoprotein E system in man","volume":"32","author":"Utermann","year":"1980","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2004.09.003_bib28","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch Neurol"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458004002933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458004002933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T19:51:40Z","timestamp":1548964300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458004002933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0197458004002933"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.09.003","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}